Company Filing History:
Years Active: 2020
Title: Innovations of Inventor Xiaochen Pan
Introduction
Xiaochen Pan is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on JAK kinase inhibitors. His research and inventions have the potential to impact the treatment of various diseases.
Latest Patents
Xiaochen Pan holds 1 patent for a pharmaceutical composition that contains a JAK kinase inhibitor or a pharmaceutically acceptable salt thereof. This invention specifically includes a composition featuring (3aR, 5s, 6aS)-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl(7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino) hexahydrocyclopenta [c] pyrrol-2 (1H)-carboxamide, or a pharmaceutically acceptable salt thereof, along with cellulose ether. The composition is characterized by a rapid dissolution rate and good stability, making it a valuable addition to pharmaceutical formulations.
Career Highlights
Xiaochen Pan is associated with Jiangsu Hengrui Medicine Company Ltd., where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Yun Lu and Hao Chen, who contribute to the innovative environment at Jiangsu Hengrui Medicine Company Ltd. Their collective expertise enhances the potential for groundbreaking discoveries in pharmaceuticals.
Conclusion
Xiaochen Pan's contributions to the field of pharmaceuticals through his innovative patent on JAK kinase inhibitors highlight his role as a significant inventor. His work not only showcases his expertise but also promises advancements in medical treatments.